TherapeuticsMD (TXMD) PT Lowered to $5 at Stifel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
TherapeuticsMD (TXMD) Tops Q1 EPS by 1c, Revenues Beat
May 6, 2021 7:11 AM EDTTherapeuticsMD (NASDAQ: TXMD) reported Q1 EPS of ($0.11), $0.01 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $19.9 million versus the consensus estimate of $19.77 million.
I am pleased with our ongoing execution across the organization, which is in-line with our 2021... More
